Citations for
1ALSD, IGFALS
Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins.
Fofanova-Gambetti OV, Hwa V, Kirsch S, Pihoker C, Chiu HK, Högler W, Cohen LE, Jacobsen C, Derr MA, Rosenfeld RG.
Horm Res 71(2):100-10. Epub 2009 Jan 8.PMID: 19129715 2009
2ALSD, IGFALS
Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.
Domené HM, Hwa V, Argente J, Wit JM, Camacho-Hübner C, Jasper HG, Pozo J, van Duyvenvoorde HA, Yakar S, Fofanova-Gambetti OV, Rosenfeld RG; International ALS Collaborative Group.
Horm Res 72(3):129-41. Epub 2009 Sep 1. Review.PMID: 19729943 2009
3ALSD, IGFALS
Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit.
van Duyvenvoorde HA, Kempers MJ, Twickler TB, van Doorn J, Gerver WJ, Noordam C, Losekoot M, Karperien M, Wit JM, Hermus AR.
Eur J Endocrinol 159(2):113-20. Epub 2008 May 7.PMID: 18463107 2008
4ALSD, IGFALS
Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations.
Domené HM, Scaglia PA, Lteif A, Mahmud FH, Kirmani S, Frystyk J, Bedecarrás P, Gutiérrez M, Jasper HG.
J Clin Endocrinol Metab 92(11):4444-50. Epub 2007 Aug 28.PMID: 17726072 2007